logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Institute Oncology Veneto

+390498211111
antonio.sommariva@ioveneto.it
Source: Site record.
http://www.ioveneto.it

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Istituto Oncologico Veneto (IOV) - IRCCS, located at Via Gattamelata, 64 in Padova, Italy, serves as a premier national center of excellence and a Comprehensive Cancer Centre dedicated to prevention, diagnosis, treatment, and biomedical research. Operating in close association with the University of Padua, the institute functions as the primary coordination hub for the Veneto Oncology Network.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Cancer treatment center

Business Subcategory

Source: Human-provided. Cancer treatment center
Source: Human-provided. Oncologist
Source: Trial-derived.
106Total Trials
Source: Trial-derived.
22Recruiting Trials
Source: Trial-derived.
63Active Trials
Source: Trial-derived.
34Completed Trials
Source: Trial-derived.
152Unique Conditions
Source: Trial-derived.
109Unique Sponsors

Conditions

Source: Trial-derived. Breast Cancer (5)Source: Trial-derived. Melanoma (5)Source: Trial-derived. Non Small Cell Lung Cancer (5)Source: Trial-derived. Ovarian Cancer (5)Source: Trial-derived. Metastatic Colorectal Cancer (4)Source: Trial-derived. Cholangiocarcinoma (3)Source: Trial-derived. Elderly Metastatic Colorectal Cancer Patients (3)Source: Trial-derived. Fallopian Tube Cancer (3)

Sponsors

Source: Trial-derived. European Organisation for Research and Treatment of Cancer - EORTC (7)Source: Trial-derived. Fondazione Italiana Linfomi - ETS (7)Source: Trial-derived. Incyte Corporation (7)Source: Trial-derived. AstraZeneca (6)Source: Trial-derived. Bristol-Myers Squibb (5)Source: Trial-derived. Daiichi Sankyo (5)Source: Trial-derived. Hoffmann-La Roche (5)Source: Trial-derived. GOG Foundation (4)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Specimen packaging and shipment

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Surgery / operating room

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Amenities

Amenities Available

Source: Google. Restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Ophthalmologic examination